MLS MEDICAL A/S — Credit Rating and Financial Key Figures
CVR number: 12455631
Klovenbjergvej 8, Annisse 3200 Helsinge
tel: 48286666
Income statement (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Fiscal period length | 12 | 12 | 12 | 12 | 12 |
Net sales | |||||
Gross profit | 4 178.08 | 3 545.09 | 3 768.99 | 4 814.00 | 4 148.06 |
Employee benefit expenses | -3 248.15 | -3 178.48 | -3 142.73 | -3 466.14 | -3 692.71 |
Other operating expenses | - 148.91 | ||||
Total depreciation | - 583.66 | - 591.01 | - 619.36 | - 571.73 | - 138.90 |
EBIT | 346.27 | - 224.41 | - 142.01 | 776.14 | 316.44 |
Other financial income | 60.09 | 48.46 | 35.78 | 78.13 | 38.29 |
Other financial expenses | -99.17 | -67.73 | - 115.10 | -53.83 | -98.12 |
Pre-tax profit | 307.18 | - 243.68 | - 221.33 | 800.44 | 256.61 |
Income taxes | -64.60 | 56.06 | 49.02 | - 175.80 | -56.40 |
Net earnings | 242.59 | - 187.62 | - 172.31 | 624.65 | 200.22 |
Assets (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Intangible assets total | |||||
Machinery and equipment | 1 921.32 | 1 819.87 | 1 200.51 | 709.32 | 570.42 |
Tangible assets total | 1 921.32 | 1 819.87 | 1 200.51 | 709.32 | 570.42 |
Other receivables | 108.00 | 108.00 | 108.00 | 108.00 | 108.00 |
Investments total | 108.00 | 108.00 | 108.00 | 108.00 | 108.00 |
Long term receivables total | |||||
Inventories total | |||||
Current trade debtors | 770.60 | 948.14 | 1 364.41 | 2 193.45 | 868.97 |
Prepayments and accrued income | 277.81 | 273.88 | 98.02 | 202.03 | 51.19 |
Current other receivables | 81.60 | 127.18 | 271.55 | 130.04 | 155.31 |
Current deferred tax assets | 22.13 | ||||
Short term receivables total | 1 130.01 | 1 371.33 | 1 733.98 | 2 525.52 | 1 075.47 |
Other current investments | 42.42 | 61.33 | 82.14 | 88.09 | 92.82 |
Cash and bank deposits | 3 369.41 | 2 726.48 | 2 929.21 | 3 602.11 | 3 457.55 |
Cash and cash equivalents | 3 411.83 | 2 787.81 | 3 011.35 | 3 690.20 | 3 550.37 |
Balance sheet total (assets) | 6 571.16 | 6 087.02 | 6 053.84 | 7 033.03 | 5 304.26 |
Equity and liabilities (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Share capital | 1 000.00 | 1 000.00 | 1 000.00 | 1 000.00 | 1 000.00 |
Shares repurchased | 1 000.00 | 1 000.00 | |||
Retained earnings | 3 645.50 | 3 888.08 | 3 700.46 | 2 528.15 | 2 152.80 |
Profit of the financial year | 242.59 | - 187.62 | - 172.31 | 624.65 | 200.22 |
Shareholders equity total | 4 888.08 | 4 700.46 | 4 528.15 | 5 152.80 | 4 353.01 |
Provisions | 181.12 | 147.19 | 80.00 | 4.68 | 11.96 |
Non-current liabilities total | |||||
Current loans from credit institutions | 0.00 | ||||
Advances received | 315.06 | 556.31 | 287.94 | 383.95 | 402.15 |
Current trade creditors | 135.96 | 218.57 | 393.07 | 1 060.56 | 136.33 |
Current owed to group member | 159.03 | 102.30 | 80.17 | 18.17 | 37.40 |
Short-term deferred tax liabilities | 102.30 | 18.17 | 40.81 | 48.80 | |
Other non-interest bearing current liabilities | 789.61 | 362.19 | 666.33 | 372.07 | 314.61 |
Current liabilities total | 1 501.96 | 1 239.37 | 1 445.69 | 1 875.56 | 939.28 |
Balance sheet total (liabilities) | 6 571.16 | 6 087.02 | 6 053.84 | 7 033.03 | 5 304.26 |
Try the full version of our system for free
Create your own estimates for any company
Valuation analysis
See instructions

... and more!
No registration needed.